Podcast Episodes
Back to Search
Pharmaceutical Executive Daily: Novo Nordisk Commits $506 Million to Ireland Manufacturing Site
In today’s Pharmaceutical Executive Daily, industry leaders examine how to measure AI’s return on investment across the life sciences value chain, No…
2 months, 2 weeks ago
Pharmaceutical Executive Daily: FDA Approves Palynziq and Sogroya
In today’s Pharmaceutical Executive Daily, the FDA approves an expanded indication for Palynziq in patients aged 12 and older, Sogroya becomes the fi…
2 months, 2 weeks ago
Pharmaceutical Executive Daily: FDA Approves Hernexeos
In today’s Pharmaceutical Executive Daily, the FDA approves Hernexeos under a national priority voucher program, industry leaders explore the expansi…
2 months, 3 weeks ago
Pharmaceutical Executive Daily: Alkermes' CEO Succession Plan
In today’s Pharmaceutical Executive Daily, Alkermes outlines its CEO succession plan following Richard Pops’ retirement announcement, leadership chan…
2 months, 3 weeks ago
The Ron Lanton Report: Is Healthcare Consolidation Reaching Its Limits?
The episode will explore structural implications for supply chains, distribution models, and international strategy, not a political discussion, but …
2 months, 3 weeks ago
Pharmaceutical Executive Daily: FDA Approves Braftovi
In today’s Pharmaceutical Executive Daily, the FDA approves Braftovi for mutant metastatic colorectal cancer, Novo Nordisk and GSK announce major dea…
2 months, 3 weeks ago
Pharmaceutical Executive Daily: Novo Nordisk Announces Price Reductions for GLP-1 Products
In today’s Pharmaceutical Executive Daily, AbbVie invests $380 million to expand API manufacturing capacity while Bora Pharmaceuticals and GSK enter …
2 months, 3 weeks ago
Pharmaceutical Executive Daily: BioNTech Files Patent iInfringement Lawsuit Against Moderna
In today’s Pharmaceutical Executive Daily, BioNTech files a patent infringement lawsuit against Moderna, the Supreme Court rules against a large numb…
3 months ago
Pharmaceutical Executive Daily: FDA Plans to Remove Two Study Requirement for New Drug Approvals
In today’s Pharmaceutical Executive Daily, the FDA reportedly removes its two-study requirement for new drug approvals, Hims & Hers enters a $1 billi…
3 months ago
Pharmaceutical Executive Daily: FDA Initiates Review of Moderna’s Seasonal Influenza Vaccine
In today’s Pharmaceutical Executive Daily, the FDA begins reviewing Moderna’s seasonal flu vaccine under a revised regulatory approach, Eli Lilly sig…
3 months ago